Table 3 Comparisons between the high and low hs-CRP in patients treated with urokinase
|  | High hs-CRP (n = 37) | Low hs-CRP (n = 30) | P value |
|---|---|---|---|
Age (years), mean ± SD | 64.97 ± 8.66 | 64.13 ± 13.22 | 0.756 |
Male, n (%) | 24 (64.8%) | 18 (60%) | 0.682 |
Hypertension, n (%) | 27 (73%) | 21 (70%) | 0.788 |
Diabetes, n (%) | 12 (32.4%) | 14 (46.7%) | 0.234 |
Uric acid (µmol/L), Median (IQR) | 365 (317–426) | 357 (281–425) | 0.623 |
Platelet count (10^9/L), Median (IQR) | 191 (158–232) | 186(161–226) | 0.641 |
Baseline NIHSS | 4 (2 ~ 5) | 4 (2 ~ 5.25) | 0.799 |
ΔNIHSS, Median (IQR) | 0 (-1 ~ 0) | -0.5 (-1 ~ 0) | 0.223 |
Good thrombolysis response rate, n (%) | 6 (16.2%) | 6 (20%) | 0.688 |
Any intracranial hemorrhage, n (%) | 4 (10.8%) | 3 (10%) | 0.914 |